Guest guest Posted July 25, 2010 Report Share Posted July 25, 2010 #453 : Free Weekly Newsletter by Ralph W. Moss, PhD. July 25, 2010 AVASTIN: STUNNING REVERSAL In a stunning rebuke to the former director of the Food and Drug Administration (FDA), an advisory panel has recommended removing the approval of the drug Avastin (bevacizumab) for breast cancer..... To read this week's newsletter, please click here: http://www.cancerdecisions.com/content/view/549/2/lang,english/ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.